The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial
Open accessAbstract
BACKGROUND: Maternal obesity is associated with increased birthweight, and obesity and premature mortality in adult offspring. The mechanism by which maternal obesity leads to these outcomes is not well understood, but maternal hyperglycaemia and insulin resistance are both implicated. We aimed to establish whether the insulin sensitising drug metformin improves maternal and fetal outcomes in obese pregnant women without diabetes. METHODS: We did this randomised, double-blind, placebo-controlled trial in antenatal clinics at 15 National Health Service hospitals in the UK. Pregnant women (aged ≥16 years) between 12 and 16 weeks' gestation who had a BMI of 30 kg/m(2) or more and normal glucose tolerance were randomly assigned (1:1), via a web-based computer-generated block randomisation procedure (block size of two to four), to receive oral metformin 500 mg (increasing to a maximum of 2500 mg) or matched placebo daily from between 12 and 16 weeks' gestation until delivery of the baby. Randomisation was stratified by study site and BMI band (30-39 vs ≥40 kg/m(2)). Participants, caregivers, and study personnel were masked to treatment assignment. The primary outcome was Z score corresponding to the gestational age, parity, and sex-standardised birthweight percentile of liveborn babies delivered at 24 weeks or more of gestation. We did analysis by modified intention to treat. This trial is registered, ISRCTN number 51279843. FINDINGS: Between Feb 3, 2011, and Jan 16, 2014, inclusive, we randomly assigned 449 women to either placebo (n=223) or metformin (n=226), of whom 434 (97%) were included in the final modified intention-to-treat analysis. Mean birthweight at delivery was 3463 g (SD 660) in the placebo group and 3462 g (548) in the metformin group. The estimated effect size of metformin on the primary outcome was non-significant (adjusted mean difference -0·029, 95% CI -0·217 to 0·158; p=0·7597). The difference in the number of women reporting the combined adverse outcome of miscarriage, termination of pregnancy, stillbirth, or neonatal death in the metformin group (n=7) versus the placebo group (n=2) was not significant (odds ratio 3·60, 95% CI 0·74-17·50; p=0·11). INTERPRETATION: Metformin has no significant effect on birthweight percentile in obese pregnant women. Further follow-up of babies born to mothers in the EMPOWaR study will identify longer-term outcomes of metformin in this population; in the meantime, metformin should not be used to improve pregnancy outcomes in obese women without diabetes. FUNDING: The Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Health Research partnership.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure Trial profile *Change in eligibility from screening of notes to recruitment visit (unable to arrange recruitment visit before 16 weeks [n=26]), recruitment stopped before screening appointment (n=14), miscarriage (n=2), moved out of area (n=1), unable to provide informed consent because of difficulties with spoken English (n=5), own doctor or midwife advised against participation (n=4), duplicate note screening number issued in error (n=4). †3 months after birth.](/paper-figures/ddb4f26800dc402186a0f6627314255f/effect-of-metformin-on-maternal-and-fetal-outcomes-in-obese-pregnant-women-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“By contrast, in the EMPOWaR trial, compliance was defined as ingestion of at least one tablet for at least 29% of the days between randomization and delivery, and only 67% of women fulfilled this criterion(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“It is also noteworthy that only 13% (443/3329) of eligible patients consented to participate in the EMPOWaR study, whereas 47% (400/844) of eligible women were recruited to the Fetal Medicine Foundation study, making the latter group more representative of women who meet the study’s eligibility criteria and to whom the study’s results apply.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“By contrast, in the EMPOWaR trial, compliance was defined as ingestion of at least one tablet for at least 29% of the days between randomization and delivery, and only 67% of women fulfilled this criterion(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Childhood predictors of adult obesity: a systematic review.
Parsons, T. J., Power, C., Logan, S., & Summerbell, C. (1999) · PubMed · Cited by 1,001
Birth Weight and Adult Hypertension, Diabetes Mellitus, and Obesity in US Men
Curhan, G. C., Willett, W. C., Rimm, E. B., Spiegelman, D. L., Ascherio, A., & Stampfer, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.12.3246 · Cited by 917
Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview
O'Brien, T., Ray, J. G., & Chan, W. (2003) · Epidemiology · doi:10.1097/00001648-200305000-00020 · Cited by 908
Catalano, P., & Ehrenberg, H. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00989.x · Cited by 828
Thangaratinam, S., Rogozinska, E., Jolly, K., Glinkowski, S., Roseboom, T., Tomlinson, J. W., Kunz, R., Mol, B. W., Coomarasamy, A., & Khan, K. S. (2012) · BMJ · doi:10.1136/bmj.e2088 · Cited by 802
Cited by
Sorted by citations
Items 101–200 of 262
Prediction of preeclampsia in asymptomatic women
Lee, N. M. W., Chaemsaithong, P., & Poon, L. C. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102436 · Cited by 23
Giving a good start to a new life via maternal brain allostatic adaptations in pregnancy
Russell, J. A., & Brunton, P. J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.02.003 · Cited by 24
Fougner, S. L., Vanky, E., Løvvik, T. S., & Carlsen, S. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0254895 · Cited by 23
Moran, L., Fraser, L. M., Sundernathan, T., Deussen, A. R., Louise, J., Yelland, L. N., Grivell, R. M., Macpherson, A., Gillman, M. W., Robinson, J. S., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0790-z · Cited by 22
Schoenaker, D. A. J. M., Vergouwe, Y., Soedamah‐Muthu, S. S., Callaway, L. K., & Mishra, G. D. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.021 · Cited by 22
Monod, C., Kotzaeridi, G., Linder, T., Yerlikaya‐Schatten, G., Wegener, S., Mosimann, B., Henrich, W., Tura, A., & Göbl, C. S. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14688 · Cited by 21
Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
Raperport, C., Chronopoulou, E., & Homburg, R. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1889366 · Cited by 21
Bioenergetics adaptations and redox homeostasis in pregnancy and related disorders
Sanchez-Aranguren, L. C., & Nadeem, S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04215-0 · Cited by 22
Role of first‐trimester umbilical vein blood flow in predicting large‐for‐gestational age at birth
Rizzo, G., Mappa, I., Bitsadze, V. O., Słodki, M., Khizroeva, J. K., Makatsariya, A. D., & D’Antonio, F. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20408 · Cited by 21
Balani, J., Hyer, S. L., Syngelaki, A., Akolekar, R., Nicolaides, K. H., Johnson, A., & Shehata, H. A. (2017) · Obstetric Medicine · doi:10.1177/1753495x17725465 · Cited by 20
Prevention of Hypertensive Disorders of Pregnancy—Is There a Place for Metformin?
Poniedziałek‐Czajkowska, E., Mierzyński, R., Dłuski, D. F., & Leszczyńska‐Gorzelak, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132805 · Cited by 20
Gestational diabetes mellitus—right person, right treatment, right time?
Lindsay, R. S., Mackin, S. T., & Nelson, S. M. (2017) · BMC Medicine · doi:10.1186/s12916-017-0925-2 · Cited by 22
Brown Adipose Tissue: New Challenges for Prevention of Childhood Obesity. A Narrative Review
Verduci, E., Calcaterra, V., Profio, E. D., Fiore, G., Rey, F., Magenes, V. C., Todisco, C. F., Carelli, S., & Zuccotti, G. (2021) · Nutrients · doi:10.3390/nu13051450 · Cited by 20
Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS
Ryssdal, M., Vanky, E., Stokkeland, L. M. T., Jarmund, A. H., Steinkjer, B., Løvvik, T. S., Madssen, T. S., Iversen, A., & Giskeødegård, G. F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad145 · Cited by 19
do Nascimento, I. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., Hoffmann, C. B. P. C., & Silva, J. C. (2018) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1675214 · Cited by 20
do Nascimento, I. B., Sales, W. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., & Silva, J. C. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000251 · Cited by 19
Chen, C., Huang, Y., Dong, G., Zeng, Y., & Zhou, Z. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1703943 · Cited by 18
Bello–Álvarez, L. M., Fernandez-Felix, B. M., Allotey, J., Thangaratinam, S., & Zamora, J. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70401 · Cited by 19
Managing obesity in pregnancy – An obstetric and midwifery perspective
Dodd, J. M., & Briley, A. L. (2017) · Midwifery · doi:10.1016/j.midw.2017.03.001 · Cited by 21
Lin, S., Chang, S., Kuo, C., Lin, W., Chiou, M., & Huang, Y. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03207-0 · Cited by 17
Diagnostic biomolecules and combination therapy for pre-eclampsia
Qi, J., Wu, B., Chen, X., Wei, W., & Yao, X. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01003-3 · Cited by 26
Zhang, Y., Liu, X., Yang, L., & Zou, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596145 · Cited by 16
Secondary prevention of preeclampsia
Akbar, M. I. A., Rosaudyn, R., Gumilar, K. E., Shanmugalingam, R., & Dekker, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1520218 · Cited by 16
Huhtala, M. S., Tertti, K., & Rönnemaa, T. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108456 · Cited by 16
Anness, A. R., Baldo, A., Webb, D. R., Khalil, A. A., Robinson, T. G., & Mousa, H. (2021) · Placenta · doi:10.1016/j.placenta.2021.02.021 · Cited by 16
Metformin in gestational diabetes mellitus: A double‐blind placebo‐controlled randomized trial
Tew, M. P., Tan, P. C., Saaid, R., Hong, J. G. S., & Omar, S. Z. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13718 · Cited by 19
Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood
Liu, Y., Lacey, L., Whyte, S., Quenby, S. M., Denison, F. C., Dhaun, N., Norman, J. E., Drake, A. J., & Reynolds, R. M. (2021) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174421000301 · Cited by 18
Self-citationMousa, A., Løvvik, T. S., Nikkinen, H., Carlsen, S. M., Morin-Papunen, L. C., Tertti, K., Rönnemaa, T., Syngelaki, A., Nicolaides, K. H., Shehata, H. A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-036981 · Cited by 16
Self-citationAnthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
Nilsen, G. Ø., Simpson, M. R., Hanem, L. G. E., Løvvik, T. S., Ødegård, R. A., Stokkeland, L. M. T., Andersen, M., Júlíusson, P. B., & Vanky, E. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14637 · Cited by 15
Novel therapies for diabetes mellitus in pregnancy
Feghali, M. N., & Scifres, C. (2018) · BMJ · doi:10.1136/bmj.k2034 · Cited by 16
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth‐Hansen, A. K., Salvesen, Ø. O., Hanem, E., Eggebø, T. M., Salvesen, K., Vanky, E., & Ødegård, R. A. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.2.21 · Cited by 15
Maternal gestational diabetes mellitus and offspring body mass index from 1 to 4 years
Shi, X., Wang, D., Lin, M., Su, W., Wang, L., Xiao, F., Huang, P., Liu, W., Zeng, J., Song, H., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0415 · Cited by 14
Fu, J. M., Tabbara, N., TOMLINSON, G. A., Murphy, K. E., Hamilton, J. K., & Feig, D. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088653 · Cited by 14
Nüsken, E., Turnwald, E., Fink, G., Voggel, J., Yosy, C., Kretschmer, T., Handwerk, M., Wohlfarth, M., Weber, L. T., Hucklenbruch‐Rother, E., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050663 · Cited by 14
Deussen, A. R., Louise, J., & Dodd, J. M. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12974 · Cited by 14
Management of Hypertension in the Obese Pregnant Patient
Coroyannakis, C., & Khalil, A. A. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0927-x · Cited by 14
A narrative review of metformin in pregnancy: Navigating benefit and uncertainty
McEvoy, R. P., Newman, C., Egan, A. M., & Dunne, F. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16361 · Cited by 13
Novel therapeutic and diagnostic approaches for preeclampsia
Vatish, M., Powys, V. R., & Cerdeira, A. S. (2023) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000870 · Cited by 13
Sun, X., Tavenier, A., Deng, W., Leishman, E., Bradshaw, H. B., & Dey, S. K. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox164 · Cited by 13
Yu, H., Sun, J., & Hu, H. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03380-z · Cited by 12
Allotey, J., Archer, L., Coomar, D., Snell, K. I. E., Smuk, M., Oakey, L. A., Haqnawaz, S., Betrán, A. P., Chappell, L. C., Ganzevoort, W., et al. (2023) · Health Technology Assessment · doi:10.3310/dabw4814 · Cited by 12
Chaves, C., Cunha, F., Martinho, M., Garrido, S., Silva-Vieira, M., Estevinho, C., Melo, A., Figueiredo, O., Morgado, A., Almeida, M. C., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01665-8 · Cited by 12
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond
Newman, C., Rabbitt, L., Ero, A., & Dunne, F. (2023) · Drugs · doi:10.1007/s40265-023-01899-0 · Cited by 12
Kurnaz, D., & Karaçam, Z. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01748-y · Cited by 12
Mayadunne, T., Saadati, S., Asmelash, D., Mason, T., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16418 · Cited by 12
Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice
Grace, M. R., Dotters-Katz, S. K., Zhou, C., Manuck, T. A., Boggess, K., & Bae-Jump, V. L. (2019) · American Journal of Perinatology Reports · doi:10.1055/s-0039-1683362 · Cited by 11
Prolactin and breast increase during pregnancy in PCOS: linked to long-term metabolic health?
Underdal, M. O., Salvesen, Ø. O., Schmedes, A., Andersen, M., & Vanky, E. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0002 · Cited by 11
Palomba, S., Santagni, S., Daolio, J., Gibbins, K. J., Battaglia, F. A., Sala, G. B. L., & Silver, R. M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4572-9 · Cited by 11
Quotah, O. F., Nishku, G., Hunt, J., Seed, P. T., Gill, C. A., Brockbank, A., Fafowora, O., Vasiloudi, I., Olusoga, O., Cheek, E., et al. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01021-3 · Cited by 10
Chiswick, C. A., Reynolds, R. M., Denison, F. C., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S. M., Wray, S., Weeks, A. D., et al. (2016) · Efficacy and Mechanism Evaluation · doi:10.3310/eme03070 · Cited by 11
Self-citationMetformin in women at high risk of gestational diabetes mellitus
Brink, H. S., Alkemade, M., van der Lely, A. J., & van der Linden, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.008 · Cited by 10
Antepartum Care of Women Who Are Obese During Pregnancy: Systematic Review of the Current Evidence
Carlson, N. S., Leslie, S., & Amore, A. D. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12758 · Cited by 11
Obesity, fertility and pregnancy: can we intervene to improve outcomes?
Reynolds, R. M., & Gordon, A. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0199 · Cited by 10
Self-citationManaging obesity during pregnancy—what are the options?
Dodd, J. M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.141 · Cited by 9
Dodd, J. M., Grivell, R. M., Deussen, A. R., Dekker, G., Louise, J., & Hague, W. M. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1161-z · Cited by 10
First trimester prediction and prevention of adverse pregnancy outcomes related to poor placentation
D’Silva, A., Fyfe, R., & Hyett, J. A. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000420 · Cited by 9
Piper, L., Stewart, Z., & Murphy, H. R. (2017) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2017.03.004 · Cited by 9
Prepregnancy and Gestational Interventions to Prevent Childhood Obesity
Kampmann, U., Suder, L. B., Nygaard, M., Geiker, N. R. W., Nielsen, H. S., Almstrup, K., Bruun, J. M., Magkos, F., Ovesen, P., & Catalano, P. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae724 · Cited by 8
Huang, C.-F., Tiao, M., Lin, I.-C., Huang, L., Sheen, J., Tain, Y., Hsu, C., Tsai, C., Lin, Y., & Yu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214239 · Cited by 8
Metformin in gestational diabetes mellitus
Tripathi, R., Tyagi, S., & Goel, V. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1572_16 · Cited by 8
Metformin in overweight and obese women with gestational diabetes: a propensity score-matched study
Bettencourt‐Silva, R., Neves, J. S., Ferreira, M. J., Souteiro, P., Belo, S., Oliveira, A. I., Carvalho, D. M., Namora, G., Montenegro, N. A. M. D. M., & Queirós, J. C. (2019) · Endocrine · doi:10.1007/s12020-019-02043-3 · Cited by 8
Patel, M., Battarbee, A. N., Refuerzo, J., Zork, N. M., Eichelberger, K. Y., Ramos, G. A., Olson, G., Durnwald, C. P., Landon, M. B., Aagaard, K. M., et al. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005720 · Cited by 7
Is metformin safe in pregnancy: a focus on offspring outcomes
Malek, R., & Davis, S. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2424410 · Cited by 9
Boroumand, F., Ghayur, S., Gharaaghaji, R., & Vazifekhah, S. (2022) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.7.6.524 · Cited by 7
Implications of maternal obesity on fetal growth and the role of ultrasound
O’Brien, C. M., Poprzeczny, A. J., & Dodd, J. M. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1271707 · Cited by 7
Metformin versus Placebo in Obese Pregnant Women without Diabetes
Stanford, F. C., Alfaris, N., & Misra, M. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1603067 · Cited by 295
Poprzeczny, A. J., Louise, J., Deussen, A. R., & Dodd, J. M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00618-0 · Cited by 6
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study
Brand, K. M. G., Thorén, R., Sõnajalg, J., Boutmy, E., Foch, C., Schlachter, J., Hakkarainen, K. M., & Saarelainen, L. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003056 · Cited by 7
Reassessing strategies to improve pregnancy outcomes in overweight and obese women
Catalano, P. M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30337-1 · Cited by 6
Metformin in pregnancy – safe or sorry?
Vanky, E., & Ødegård, R. A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0081-6 · Cited by 6
Perichart‐Perera, O., Mier‐Cabrera, J., Flores-Robles, C. M., Martínez-Cruz, N., Arce-Sánchez, L., Alvarado-Maldonado, I. N., Montoya-Estrada, A., Romo‐Yáñez, J., Rodríguez-Cano, A. M., Estrada‐Gutiérrez, G., et al. (2021) · Nutrients · doi:10.3390/nu14010062 · Cited by 5
van Hoorn, E. G. M., Rademaker, D., van der Wel, A. W. T., DeVries, J. H., Franx, A., van Rijn, B. B., Kooy, A., Siegelaar, S. E., Roseboom, T. J., Ozanne, S. E., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15243 · Cited by 6
Metformin use during pregnancy: Is it really safe?
Paschou, S. Α., & Wolffenbuttel, B. H. R. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12813 · Cited by 5
Pascual‐Morena, C., Cavero‐Redondo, I., Álvarez‐Bueno, C., Martínez‐Hortelano, J. A., Reina‐Gutiérrez, S., Saz‐Lara, A., de Arenas‐Arroyo, S. N., & Martínez‐Vizcaíno, V. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.796009 · Cited by 4
Usman, U. Z., Bakar, A. B. A., & Mohamed, M. (2016) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2016.06.04.1 · Cited by 4
Zhang, J., Cao, L., Wang, W., Huo, Y., Zheng, Y., Wu, F., & Gui, Y. (2022) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174422000095 · Cited by 4
Jin, F., Sun, J., Yang, Y., Li, R., Luo, M. Y., Huang, Q., & Liu, X. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15134 · Cited by 4
Review of Prediabetes and Hypertensive Disorders of Pregnancy
Carris, N. W., Nwabuobi, C. K., He, W., Bullers, K., Wilson, R. E., Louis, J. M., & Magness, R. R. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1698831 · Cited by 4
O impacto do uso da metformina para gestantes obesas na prevenção da pré-eclâmpsia
do Nascimento, I. B., Sales, W. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., & Silva, J. C. (2020) · Scientia Medica · doi:10.15448/1980-6108.2020.1.35338 · Cited by 4
TRATAMIENTO DE LA DIABETES EN EL EMBARAZO: ¿ALGO NUEVO?
Gloria López, S. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.04.014 · Cited by 5
Shaon, M. A., Farhana, F. Z., Sikder, R., Shrestha, K. P., Haque, F., Tantu, M. T., Manjur, O. H. B., Aktar, S., Koo, K. M., Ross, A. G., et al. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00056 · Cited by 3
Dempsey, A., Mumby, C., Bernatavicius, G., Roberts, S. A., & Myers, J. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1852209 · Cited by 3
Adipositas und Schwangerschaft
Schäfer-Graf, U. M. (2016) · Der Diabetologe · doi:10.1007/s11428-015-0051-8 · Cited by 3
Metformin use in gestational diabetes
Campbell, I. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00018-7 · Cited by 3
Hegerty, C. K., & Ostini, R. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069849 · Cited by 3
Neola, D., Angelino, A., Sirico, A., Murolo, C., Bartolini, G., Vigilante, L., Raffone, A., Carbone, L., Sarno, L., Saccone, G., et al. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15728 · Cited by 3
Romeo, P., D’Anna, R., & Corrado, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185387 · Cited by 4
Metformin and pregnancy outcomes in obese women
Refuerzo, J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00234-x · Cited by 3
Mann oder Frau: Ist das bei Diabetes relevant?
Harreiter, J., & Kautzky‐Willer, A. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-9793-0 · Cited by 3
Metformin: a review on its ethnobotanical source and versatile uses
Asif, M., Acharya, M., & Imran, M. (2020) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_50_19 · Cited by 3
Prädisposition/Phänotypen des Gestationsdiabetes mellitus
Kleinwechter, H. J., Demandt, N., & Nolte, A. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1217-2233 · Cited by 3
Schäfer-Graf, U. M., & Tan, S. (2022) · Der Gynäkologe · doi:10.1007/s00129-021-04894-2 · Cited by 3
Influence of Maternal Obesity on the Long-Term Health of Offspring
Johns, E. C., Stoye, D. Q., Liu, Y., & Reynolds, R. M. (2019) · Healthy ageing and longevity · doi:10.1007/978-3-030-24958-8_11 · Cited by 3
Self-citationHadar, E., Stewart, Z. A., Hod, M., & Murphy, H. R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.2508 · Cited by 3
Spin in Randomised Clinical Trial Reports of Interventions for Obesity
Lee, S., Won, J., Kim, S.-Y., Park, S. J., & Lee, H. (2017) · Korean Journal of Acupuncture · doi:10.14406/acu.2017.029 · Cited by 3
van Hoorn, E. G. M., van Dijk, P. R., Prins, J. R., Lutgers, H. L., Hoogenberg, K., Erwich, J. J., & Kooy, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056282 · Cited by 3
Reproductive outcomes in female mice offspring due to maternal metformin treatment
Velázquez, C., Herrero, Y., Prost, K., Bordaquievich, M., Neira, M., Parborell, F., & Abramovich, D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123416 · Cited by 2
Kerdsuknirund, S., Kosinan, A., Khunkaewla, P., Kupittayanant, P., Tongdee, P., Nimkuntod, P., Wray, S., & Kupittayanant, S. (2025) · Current Research in Physiology · doi:10.1016/j.crphys.2025.100139 · Cited by 2
Self-citationThe impact of metformin on placental ageing in humans and mice
Hattersley, G. J., Liu, Y., Tarry‐Adkins, J. L., Hufnagel, A., Wong, K. K., Fernandez‐Twinn, D. S., Chukanova, M., Robinson, I. G., Drake, A. J., Reynolds, R. M., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288710 · Cited by 2
Self-citationMaternal obesity alters myeloid immune function in the offspring
Lépez, M., Giacaman, C., Gómez‐Cayupán, J., & Casanello, P. C. (2025) · The Journal of Physiology · doi:10.1113/jp285929 · Cited by 2
Metadata
- Authors
- Chiswick, C., Reynolds, R. M., Denison, F., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S., Wray, S., Weeks, A., Lashen, H., Rodriguez, A., Murray, G., Whyte, S., & Norman, J. E.
- Affiliations
- MRC Centre for Reproductive Health (GB)
- British Heart Foundation Centre for Cardiovascular Science (GB)
- Edinburgh Royal Infirmary (GB)
- University of Warwick (GB)
- Liverpool Women's Hospital (GB)
- Jessop Hospital (GB)
- University of Edinburgh (GB)
- Corresponding author
- Norman, Jane E
- ORCID
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 3
- Issue
- 10
- Pages
- 778-786
- ISSN
- 2213-8587 (ISSN-L)
- PMC
- PMC4673088
- OpenAlex
- W2144199745
- Cited by
- 260
- References
- 36
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 15 · 2023: 21 · 2022: 21 · 2021: 27 · 2020: 28 · 2019: 28 · 2018: 33 · 2017: 22 · 2016: 27 · 2015: 6
- FWCI
- 33.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (103782)
- National Institute for Health and Care Research (08/246/09)
- Medical Research Council (MC_G1002463)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- metformin, maternal obesity, pregnancy, birth weight, insulin resistance, miscarriage, stillbirth, preterm birth, gestational diabetes mellitus, maternal hyperglycemia, placental growth factor, placental insufficiency, fetal growth restriction, placental DNA methylation, epigenetics
- MeSH terms
- Abortion, Spontaneous, Adult, Double-Blind Method, Female, Fetal Macrosomia, Humans, Hypoglycemic Agents, Metformin, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Diabetes, Gestational, Stillbirth, Young Adult, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
